Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas
Authors
Keywords
Glioblastoma, Prognosis, TP53, Protein phosphatase 1 α, PPP1CA
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 22, Issue 2, Pages 287-292
Publisher
Springer Nature
Online
2015-08-08
DOI
10.1007/s12253-015-9928-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53 Expression Is a Strong Marker of Inferior Survival in De Novo Diffuse Large B-Cell Lymphoma and May Have Enhanced Negative Effect With MYC Coexpression
- (2014) Yi Xie et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas
- (2014) Christine Haberler et al. CLINICAL NEUROPATHOLOGY
- Targeting the untargetable: recent advances in the selective chemical modulation of protein phosphatase-1 activity
- (2013) Jayanta Chatterjee et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit in vitro
- (2012) Jun-yang Li et al. ACTA PHARMACOLOGICA SINICA
- IDH1 Mutations in Diffusely Infiltrating Astrocytomas
- (2012) Balaram Thota et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx
- (2012) Zengxin Lu et al. CELLULAR SIGNALLING
- Exploiting the selectivity of protein phosphatase 1 for pharmacological intervention
- (2012) Pavel Tsaytler et al. FEBS Journal
- Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia
- (2012) Christoph P. Hofstetter et al. PLoS One
- Glioblastoma-Specific Protein Interaction Network Identifies PP1A and CSK21 as Connecting Molecules between Cell Cycle-Associated Genes
- (2010) J. Ladha et al. CANCER RESEARCH
- Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients
- (2010) M. R. Srividya et al. JOURNAL OF CLINICAL PATHOLOGY
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation
- (2009) Judy Qiju Wu et al. NATURE CELL BIOLOGY
- Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms
- (2009) Jie Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis
- (2008) S. P. Reddy et al. CLINICAL CANCER RESEARCH
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Characterization of the p53 Response to Oncogene-Induced Senescence
- (2008) Lidia Ruiz et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started